Actinium Pharmaceuticals Inc.

ATNM | AMEX

Price Alert Chart Builder DCF Calculator

$1.21

+$0.01 (+0.83%)

Sep 22, 2026, 12:56 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	35M	n/a	n/a	90K	n/a	n/a	n/a	n/a	n/a	n/a	81K	n/a	n/a	n/a	n/a	45K	45K	940K	23K	233K	266K	622K
Cost of Revenue	n/a	220K	-615K	n/a	n/a	n/a	204K	202K	189K	216K	199K	200K	209K	n/a	161K	221K	180K	137K	137K	n/a	n/a	n/a
Gross Profit	n/a	-220K	615K	90K	n/a	n/a	-204K	-202K	-189K	-216K	-118K	-200K	-209K	n/a	-161K	-176K	-135K	803K	-114K	233K	266K	622K
Operating Income	27.57M	-5.9M	-6.41M	-5.69M	-7.5M	-16.64M	-7.51M	-12.6M	-12.42M	-9.6M	-10.34M	-14.35M	-15.64M	-11.58M	-11.29M	-9.8M	-7.85M	-5.16M	-8.05M	-6.47M	-5.08M	-5.37M
Interest Income	n/a	381K	-1.89M	561K	625K	700K	853K	1.03M	1.07M	927K	1.02M	1.08M	461K	547K	644K	325K	83K	35K	38K	46K	54K	52K
Pretax Income	27.9M	-5.52M	-5.94M	-5.13M	-6.88M	-15.94M	-6.65M	-11.57M	-11.35M	-8.67M	-9.32M	-13.28M	-15.18M	-11.04M	-10.65M	-9.47M	-7.77M	-5.13M	-8.01M	-6.42M	-5.02M	-5.32M
Net Income	27.9M	-5.52M	-5.94M	-5.13M	-6.88M	-15.94M	-6.65M	-11.57M	-11.35M	-8.67M	-9.32M	-13.28M	-15.18M	-11.04M	-10.65M	-9.47M	-7.77M	-5.13M	-8.01M	-6.42M	-5.02M	-5.32M
Selling & General & Admin	2.06M	1.7M	2.12M	1.53M	2.62M	8.94M	2.69M	2.83M	3.59M	2.96M	2.31M	2.73M	4.56M	3.74M	3.96M	3.07M	3.23M	1.74M	2.66M	1.99M	1.71M	1.72M
Research & Development	5.38M	4.2M	4.91M	4.25M	4.88M	7.7M	4.61M	9.57M	8.64M	6.42M	7.92M	11.42M	10.87M	7.85M	7.17M	6.55M	4.48M	4.23M	5.28M	4.71M	3.63M	4.28M
Other Expenses	n/a	-220K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	7.44M	5.68M	7.03M	5.78M	7.5M	16.64M	7.3M	12.4M	12.23M	9.38M	10.23M	14.15M	15.43M	11.58M	11.13M	9.62M	7.72M	5.97M	7.93M	6.7M	5.34M	5.99M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	5.9M	6.41M	5.78M	7.5M	16.64M	7.51M	12.6M	12.42M	9.6M	10.42M	14.35M	15.64M	11.58M	11.29M	9.84M	7.9M	6.1M	8.07M	6.7M	5.34M	5.99M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	31.4M	31.24M	31.2M	31.2M	31.2M	31.2M	31.2M	31.07M	30.1M	27.89M	27.63M	27.06M	26.22M	25.7M	25.68M	24.93M	23.73M	22.14M	21.54M	21.54M	20.23M	18.38M
Shares Outstanding (Diluted)	31.41M	31.24M	31.2M	31.2M	31.2M	31.2M	31.2M	31.07M	30.1M	27.89M	27.63M	27.06M	26.22M	25.7M	25.68M	25.17M	23.73M	22.14M	21.54M	21.54M	20.23M	18.38M
EPS (Basic)	0.89	-0.18	-0.19	-0.16	-0.22	-0.51	-0.21	-0.37	-0.38	-0.31	-0.34	-0.49	-0.58	-0.43	-0.39	-0.37	-0.33	-0.23	-0.37	-0.30	-0.25	-0.29
EPS (Diluted)	0.89	-0.18	-0.19	-0.16	-0.22	-0.51	-0.21	-0.37	-0.38	-0.31	-0.34	-0.49	-0.58	-0.43	-0.39	-0.36	-0.33	-0.23	-0.37	-0.30	-0.25	-0.29
EBITDA	27.57M	-5.3M	-5.73M	-4.93M	-6.67M	-15.73M	-6.45M	-11.37M	-11.16M	-8.45M	-9.13M	-13.08M	-14.97M	-10.86M	-10.49M	-9.25M	-7.59M	-4.99M	-7.87M	-6.29M	-4.89M	-5.25M
EBIT	n/a	-5.52M	-5.94M	-5.13M	-6.88M	-15.94M	-6.65M	-11.57M	-11.35M	-8.67M	-9.32M	-13.28M	-15.18M	-11.04M	-10.65M	-9.47M	-7.77M	-5.13M	-8.01M	-6.42M	-5.02M	-5.37M
Depreciation & Amortization	n/a	220K	206K	206K	204K	205K	204K	202K	189K	216K	199K	200K	209K	182K	161K	221K	180K	137K	137K	133K	129K	125K